10% Off
Edeloss20 mg+50 m
Furosemide + Spironolactone
Incepta Pharmaceuticals Ltd.
৳72.00
Add to cart
Diretic20 mg+50 mg
Tablet
Furosemide + Spironolactone
Drug International Ltd.
Product Code : 5071
10% Off
Best PriceTk
/
1
Alternatives
See All
10% Off
Edenil20 mg+50 m
Furosemide + Spironolactone
Eskayef Bangladesh Ltd.
৳7.20
Add to cart
10% Off
Laxur20 mg+50 m
Furosemide + Spironolactone
Healthcare Pharmacuticals Ltd.
৳7.20
Add to cart
10% Off
Spirocard Plus20 mg+50 m
Furosemide + Spironolactone
Popular Pharmaceuticals Ltd.
৳72.00
Add to cart
10% Off
Edemide20 mg+50 m
Furosemide + Spironolactone
ACME Laboratories Ltd.
৳7.23
Add to cart
10% Off
Frusin Plus20 mg+50 m
Furosemide + Spironolactone
Opsonin Pharma Ltd.
৳5.44
Add to cart
10% Off
Fruson20 mg+50 m
Furosemide + Spironolactone
Ibn-Sina Pharmaceuticals Ltd.
৳5.40
Add to cart
8% Off
Lasilactone20 mg+50 m
Furosemide + Spironolactone
Synovia Pharma PLC
৳5.56
Add to cart
10% Off
Frucard20 mg+50 m
Furosemide + Spironolactone
Navana Pharmaceuticals Ltd.
৳7.20
Add to cart
10% Off
Frusiton20 mg+50 m
Furosemide + Spironolactone
Globe Pharmaceuticals Ltd.
৳54.00
Add to cart
10% Off
Furo Plus20 mg+50 m
Furosemide + Spironolactone
Beacon Pharmaceuticals Ltd.
৳5.42
Add to cart
10% Off
Lacitone20 mg+50 m
Furosemide + Spironolactone
General Pharmaceuticals Ltd.
৳5.44
Add to cart
10% Off
Laxicon20 mg+50 m
Furosemide + Spironolactone
The White Horse Pharma
৳5.40
Out Of Stock
10% Off
Tonemide20 mg+50 m
Furosemide + Spironolactone
Pacific Pharmaceuticals Ltd.
৳5.40
Add to cart
10% Off
Uritone20 mg+50 m
Furosemide + Spironolactone
Renata Limited
৳7.20
Add to cart
10% Off
Urospin20 mg+50 m
Furosemide + Spironolactone
Biopharma Laboratories Ltd.
৳5.42
Out Of Stock
Medicine overview
Indications of Diretic 20 mg+50 mg
Frusemide & Spironolactone combination is indicated in-
Essential hypertension
Chronic congestive heart failure
Hepatic cirrhosis, with collection of fluid in the abdominal cavity (ascites)
Swelling due to excess fluid retention (edema)
Hyperaldosteronism
Resistant edema associated with secondary hyperaldosteronism
Theropeutic Class
Potassium-sparing diuretics, Potassium-sparing diuretics & Aldosterone antagonists
Pharmacology
Spironolactone (potassium sparing diuretic) and Furosemide (loop diuretic) have different but complementary mechanisms and sites of action. Therefore, when given together they produce additive or synergistic diuretic. The Furosemide component inhibits the Na+/K+/2Cl- co-transporter in the ascending Loop of Henle and blocks the reabsorption of sodium, potassium and chloride ions; thereby increasing the quantity of sodium and the volume of water excreted in the urine. This characteristically induces potassium loss. The spironolactone component inhibits the reabsorption of sodium in exchange for potassium at the distal tubule by antagonising the action of aldosterone so that sodium excretion is greatly favoured and the excess loss of potassium, induced by the Furosemide, is reduced
Dosage & Administration of Diretic 20 mg+50 mg
Furosemide 20 and spironolactone 50 mg: 1 to 4 tablets daily (20 to 80 mg of Furosemide and 50 to 200 mg of spironolactone) according to the patient’s response.Furosemide 40 and spironolactone 50 mg: For previously stabilized patients requiring higher dosage of spironolactone and Furosemide, This tablet can be used at a dose of one to two tablets daily (Furosemide 40 to 80 mg and spironolactone 50 to 100 mg).
Dosage of Diretic 20 mg+50 mg
Furosemide 20 and spironolactone 50 mg: 1 to 4 tablets daily (20 to 80 mg of Furosemide and 50 to 200 mg of spironolactone) according to the patient’s response.Furosemide 40 and spironolactone 50 mg: For previously stabilized patients requiring a higher dosage of spironolactone and Furosemide, This tablet can be used at a dose of one to two tablets daily (Furosemide 40 to 80 mg and spironolactone 50 to 100 mg).Use in children: Spironolactone and Furosemide is not suitable for use in children. Spironolactone and Furosemide may both be excreted more slowly in the elderly.
Interaction of Diretic 20 mg+50 mg
When taken together with ACE inhibitors or potassium salts there is an increased risk of hyperkalemia. Spironolactone increases the levels of cardiac glycosides such as digoxin in the blood and this may result in digitalis toxicity. Corticosteroids may cause hypokalemia if they are used with Spironolactone. The blood pressure lowering and diuretic effects of Furosemide may be reduced or abolished when used together with indomethacin and possibly other non-steroidal anti-inflammatory drugs (NSAIDs). Furosemide may increase the ototoxicity of aminoglycoside antibiotics. Simultaneous administration of sucralfate and Furosemide may reduce the natriuretic and anti-hypertensive effect of Furosemide.
Contraindications
Contraindicated in patients with anuria, acute renal insufficiency, rapidly deteriorating or severe impairment of renal function (creatinine clearance <30 ml/min), hyperkalaemia, Addison's disease and in patients who are hypersensitive to Spironolactone, Furosemide or sulphonamides.
Side Effects of Diretic 20 mg+50 mg
Spironolactone may give rise to headache and drowsiness and gastrointestinal distress, including cramp and diarrhoea. Ataxia, mental confusion, and skin rashes have been reported as side effect. Gynaecomastia is not uncommon and in rare cases breast enlargement may persist. Other endocrine disorders including hirsutism, deepening of the voice, menstrual irregularities and impotence. Transient increase in blood-urea-nitrogen concentrations may occur and mild acidosis has been reported. Spironolactone may cause hyponatremia and hyperkalemia. Excessive diuresis may result in dehydration and reduction in blood volume with circulatory collapse with the possibility of vascular thrombosis and embolism particularly in elderly patients. Serious depletion of potassium and magnesium may lead to cardiac arrhythmias.
Pregnancy & Lactation
Pregnancy: Spironolactone and its metabolites may cross the placental barrier. The use of spironolactone in pregnant women requires that the anticipated benefit be weighed against the possible hazards to the mother and fetus. Animal teratology studies indicate that Furosemide may cause fetal abnormalities. Therefore, Furosemide should only be used in women in child bearing age when appropriate contraceptive measures are taken or if the potential benefits justify the potential risks to the fetus.Lactation: Metabolites of Spironolactone have been detected in breast milk. If use of Spironolactone is considered essential, an alternative method of infant feeding should be instituted. Furosemide is excreted in breast milk and breast-feeding should be discontinued if treatment is essential.
Precautions & Warnings
Caution should be taken in patients liable to electrolyte deficiency. This preparation should also be used with caution in diabetes, enlarged prostate, hypotension and in hypovolemia.
Overdose Effects of Diretic 20 mg+50 mg
Symptoms of overdosage include drowsiness, mental confusion, dizziness, diarrhea and vomiting etc. due to excessive diuresis. Treatment should be aimed at the replacement of fluid and correction of any electrolyte imbalance.
Storage Conditions
Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.
Use In Special Populations
Use in children: Spironolactone and Furosemide is not suitable for use in children. Spironolactone and Furosemide may both be excreted more slowly in the elderly.
Drug Classes
Potassium-sparing diuretics, Potassium-sparing diuretics & Aldosterone antagonists
Mode Of Action
Spironolactone (potassium sparing diuretic) and Furosemide (loop diuretic) have different but complementary mechanisms and sites of action. Therefore, when given together they produce additive or synergistic diuretic. The Furosemide component inhibits the Na+/K+/2Cl- co-transporter in the ascending Loop of Henle and blocks the reabsorption of sodium, potassium and chloride ions; thereby increasing the quantity of sodium and the volume of water excreted in the urine. This characteristically induces potassium loss. The spironolactone component inhibits the reabsorption of sodium in exchange for potassium at the distal tubule by antagonising the action of aldosterone so that sodium excretion is greatly favoured and the excess loss of potassium, induced by the Furosemide, is reduced
Pregnancy
Pregnancy: Spironolactone and its metabolites may cross the placental barrier. The use of spironolactone in pregnant women requires that the anticipated benefit be weighed against the possible hazards to the mother and fetus. Animal teratology studies indicate that Furosemide may cause fetal abnormalities. Therefore, Furosemide should only be used in women in child bearing age when appropriate contraceptive measures are taken or if the potential benefits justify the potential risks to the fetus.Lactation: Metabolites of Spironolactone have been detected in breast milk. If use of Spironolactone is considered essential, an alternative method of infant feeding should be instituted. Furosemide is excreted in breast milk and breast-feeding should be discontinued if treatment is essential.
Disclaimer
The information provided is accurate to our best practices, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy. The absence of specific information about a drug should not be seen as an endorsement. We are not responsible for any consequences resulting from this information, so consult a healthcare professional for any concerns or questions.
